Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$1.46M
18.41K shares
What this filing means
BOULDING MARK ELLIOTT plans to sell 18.41K shares of PTC THERAPEUTICS, INC. valued at approximately $1.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001959173-26-006063
Officer· Exec. VP and CLO
Since Jan 2019
18.41K
Shares to sell
$1.46M
Approx. market value
2.81K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/17/2026
2.81KTotal acquired2.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Stock Option Exercise Cash | 2.81K | — |
| Total | 2.81K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.08K
Market value
$432.1K
7/6/2026
—Completed
Units to sell
10.52K
Market value
$827.6K
6/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.81K
Market value
$201.7K
8/17/2026
Total
Units
18.41K
Value
$1.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/6/2026 | 5.08K | $432.1K | — | Completed |
6/17/2026 | 10.52K | $827.6K | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 2.81K | $201.7K | NASDAQ | Planned |
| Total | 18.41K | $1.46M | ||